Osteoporosis & Bone Health
Osteoporosis currently affects about two million Canadians, but many more are at risk of developing this debilitating condition. Generally, young women achieve peak bone mass by the age of 20, and...
Rheumatoid Arthritis
Rheumatoid arthritis is a chronic condition that causes the body’s immune system to attack the joints, resulting in inflammation, swelling and pain. Finding an effective medication that helps...
Biologics & Biosimilars
Now more than ever, Canadians need to see changes in how heart health is managed. With more than 2.4 million Canadians suffering from heart disease, and thousands dying every year as a result,...
Biologics & Biosimilars
Drugs can be categorized as being synthetically or biologically produced. Synthetic (conventional) therapies are made from chemical processes — like mixing, heating and cooling — to create the...
Biologics & Biosimilars
Biosimilars are biologic medicines that aim to provide similar therapeutic effects to an original biologic medicine that has already been authorized for sale by Health Canada and prescribed by...
Biologics & Biosimilars
A biologic medicine (a term which is commonly shortened to a biologic) is any medicine that has been made from living material, which could include blood, human cells, animal cells, bacteria and...
Biologics & Biosimilars
Like their name implies, biosimilars are similar to originator biologics but not identical. In fact, because biologic and biosimilar medicines are created from living cell lines, no two medicines...
Biologics & Biosimilars
Accurate communication between primary healthcare providers, nurses, pharmacists and patients is one of the tenets of quality care. Pharmaceutical naming, using brand names (the names given to...
View More Posts
The Biotechnologist is an online magazine that captures perspectives on science, innovation and the future of medicines.
The Biotechnologist is an online magazine that captures perspectives on science, innovation and the future of medicines.